Biolevox™ HA

  • Biolevox™ HA 1
  • Biolevox™ HA 2
Product Description

The Biolevox™ HA product family is based on hyaluronic acid with carefully selected concentration, viscosity and molecular parameters tailored to specific clinical applications.

  • Biolevox™ HA ONE delivers 120 mg of highly purified HA in a single injection. Its USP is clinically confirmed OA symptom relief and improved joint function lasting up to 12 months.
  • Biolevox™ HA 2.2% provides 44 mg HA in 2 ml through a 3-injection course. Its USP is versatility: it can be used in different joints and supports pain relief and mobility after arthroscopy.
  • Biolevox™ HA MINI is designed for small joints, including the hand, foot, ankle and facet joints. Its USP is precise viscosupplementation that relieves pain and improves mobility for months.
  • Biolevox™ HA TENDON is designed for tendinopathy and enthesopathy. Its USP is targeted anti-catabolic action that supports tendon ...

Read more Show less

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • Founded:
    2008
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
CMO/CDMO
Licensee
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Medical Devices
View company profile
Categories
more categories Show less
Specifications
  • Details
    The Biolevox™ HA product family is based on hyaluronic acid:
  • Biolevox™ HA ONE – 120 mg HA / 4.8 ml; single-injection therapy for osteoarthritic joints, helping reduce pain and stiffness and improve mobility.
  • Biolevox™ HA 2.2% – 44 mg HA / 2 ml; versatile intra-articular therapy for different joints, including the knee, elbow and shoulder; also used after arthroscopy.
  • Biolevox™ HA MINI – 16 mg HA / 1 ml; designed for precise injections into small joints, including the ankle, facet and hand joints.
  • Biolevox™ HA TENDON – 32 mg HA / 2 ml; designed for painful tendon disorders, including tendinopathy and enthesopathy.
  • Selling Points
    Bone & Joint Health; Brand Name; Biolevox™ HA ONE
    • Clinically confirmed effect up to 12 months
    • Reduces pain and stiffness, improves mobility
    • Highly purified, non-animal HA from bacterial fermentation   
    Biolevox™ HA 2.2%
    • Versatile use in different joints
    • Three-injection therapy at weekly intervals
    • Clinically effective after arthroscopic procedures 
    Biolevox™ HA MINI
    • Designed specifically for small joints
    • Precise intra-articular administration
    • Helps reduce pain and improve joint mobility for months 
    Biolevox™ HA TENDON
    • Designed for tendinopathy and enthesopathy
    • Strong anti-catabolic and biological action
    • Supports tendon healing, pain relief and functional recovery
  • Supplied from
    Poland
    • More specifications Fewer specifications
    Sales Markets
    Show more Show less

    Biovico Sp. z o.o.

    • Country/Region:
      Poland
    • Founded:
      2008
    • On CPHI since:
      2015
    • Certificates:
      5
    • Employees:
      100 - 249
    Company types
    CMO/CDMO
    Licensee
    Manufacturer/Innovator
    Wholesale/Retail
    Primary activities
    Medical Devices
    View company profile

    More Products from Biovico Sp. z o.o. (19)

    • Biolevox™ Complex

      Product Biolevox™ Complex

      Biolevox™ Complex supplements with ingredients occuring naturally in the joint structures and supporting joint function. Complex formula protects articular cartilage, synovial fluid and subchondral bone.

    • Chondrovox™ bis

      Product Chondrovox™ bis

      Chondrovox™ is based on chondroitin sulfate, which occurs naturally in articular cartilage. In combination with proteins creates proteoglycans responsible for proper flexibility and mechanical properties of cartilage. Produced in accordance with strict rules of European Pharmacopoeia standards.
    • DKK DERM™ procedure kit

      Product DKK DERM™ procedure kit

      DKK DERM™ kit is designed to obtain an autologous blood-derived product enriched with the DKK-1 protein (DKK-PRP). The DKK DERM™ separation device features an innovative borosilicate platelet activator that selectively induces platelet activation, leading to the release of hig...
    • AOORA™

      Product AOORA™

      Three AOORA™ procedure packs designed for isolation and separation of high quality blood derived products. The obtained platelet-rich plasma (PRP) contains minimum 1 milion of platelets in 1 μl of plasma, which has the direct impact on the high amount of growth factors delivered in order to revitalize skin.
    • Flavya™ Post Treatment Occlusive Face Mask

      Product Flavya™ Post Treatment Occlusive Face Mask

      Flavya™ Post Treatment Occlusive Face Mask is a medical device in the form of a biocellulose mask soaked in hyaluronic acid. Thanks to its occlusive properties, the mask creates a protective barrier on the skin, which is particularly important after medical esthetic  treatments. Additionally, ...
    • Flavya™ Post Treatment Occlusive Patch

      Product Flavya™ Post Treatment Occlusive Patch

      Flavya™ Post Treatment Occlusive Patch is a medical device in the form of a biocellulose dressing soaked in hyaluronic acid, available in two sizes:
      • 10 × 10 cm • 10 × 20 cm. It is intended for use on specific areas of the body, such as the neck, décolletage, perioral area, and ha...
    • Lipotris™

      Product Lipotris™

      Liposomal intra-articular gel composite - new generation viscosupplement which ensures supreme lubrication mechanism. Lipotris™ therapy provides accelerated pain relief with sustainable duration of clinical effect. The TRIAD OF AN IDEAL LUBRICATION provides ultra-low friction ratio between cartilage surfac...
    • Xerthra™ kits

      Product Xerthra™ kits

      Xerthra™ PRP kit is a new generation, high-performance platelet (PLT) separation device, dedicated to preparation of platelet-rich plasma (PRP) from patient’s blood. Large number of growth factors released from PLTs delivered by PRP will lead to improvement of regenerative properties of patient’s cell...
    • Wint™ kit

      Product Wint™ kit

      Wint ™ is a unique, high-performance separation device designed to obtain blood derived product rich in DKK-1 (Dickkopf-1) protein- a natural, endogenous inhibitor or Wnt signaling pathway from patient's own blood. Wint™ separation device, due to presence of the exclusive borosilicate activator trigge...
    • FLAVYA™

      Product FLAVYA™

      Flavya™ products are injectable medical devices containing native hyaluronic acid (HA). Flavya™ complements HA deficiencies in dermis, attracts water molecules, neutralizes free radicals, creates conditions for regeneration processes and production of new collagen and elastin fibres in the skin.

    • Biolevox™ HA 2.2%

      Product Biolevox™ HA 2.2%

      Biolevox™ HA 2.2% is a hyaluronic acid (HA) gel designed for a three intra-articular injection into the osteoarthritis (OA) affected in order to ameliorate symptoms of the osteoarthritis (OA) in synovial joint. Designed HA-based gel contains 44 mg of hyaluronate in 2 ml pre-filled syringe. The co...
    • Biolevox™ HA mini

      Product Biolevox™ HA mini

      Biolevox™ HA MINI is a hyaluronic acid (HA) gel dedicated to the intra-articular injection into the small synovial joints effected by the osteoarthritis (OA) disease. Specified HA-based gel contains 16 mg of sodium hyaluronate in 1 ml pre-filled syringe. Biolevox™ HA MINI is intended for intra-ar...
    show all 19 other products

    Biovico Sp. z o.o. resources (4)